AgomAb Therapeutics NV (AGMB)

CIK 2020932 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for AgomAb Therapeutics NV.

Recent SEC filings

FiledFormAccession number
Oct 22, 202640001445826-26-000015
Oct 13, 20266-K0001104659-26-115567
Oct 9, 202640001445826-26-000014
Oct 7, 202640002120886-26-000001
Oct 7, 202640001445826-26-000013
Oct 7, 202640002119332-26-000001
Oct 1, 20266-K0001104659-26-112564
Sep 15, 202630001104659-26-107914
Sep 15, 202640001104659-26-107916
Sep 15, 202640001104659-26-107915
Sep 15, 202630001104659-26-107912
Sep 14, 20266-K0001104659-26-107500
Sep 11, 20266-K0001104659-26-107117
Aug 10, 20266-K0001104659-26-093390
Aug 6, 20266-K0001104659-26-091992
Jun 23, 20266-K0001104659-26-076819
May 27, 20266-K0001104659-26-066590
May 15, 2026SCHEDULE 13G0001104659-26-062718
May 15, 2026SCHEDULE 13G0001172661-26-002216
May 6, 2026SCHEDULE 13G0001193125-26-207455
Apr 24, 20266-K0001104659-26-048615
Apr 23, 202620-F0001104659-26-047872
Apr 16, 2026SCHEDULE 13G0001213900-26-044365
Mar 18, 202630001104659-26-030842
Mar 18, 202630001104659-26-030839